🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested
Locally advanced lung cancer (LALC) has poor prognosis despite multimodal t...
Status
Not Yet Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2026-07-31
Trial ID
NCT07752589
Treatments Being Tested
The purpose of this observational study is to collect and evaluate real-wor...
Status
Recruiting
Location
Klinikverbund Allgaeu
Start Date
2023-11-30
Trial ID
NCT06169956
Treatments Being Tested
This study investigates metabolic glycolytic biomarkers obtained from radio...
Status
Recruiting
Location
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HC-FMRP-USP)
Start Date
2025-02-25
Trial ID
NCT07084610
Treatments Being Tested
This phase III trial compares standard therapy given after surgery (adjuvan...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-12-11
Trial ID
NCT06632327
This is a phase 2 trial seeking to define the safety and activity of gemcit...
Status
Completed
Location
City of Hope
Start Date
2018-07-13
Trial ID
NCT03558087
Treatments Being Tested
The purpose of this study is to assess whether the addition of the immune c...
Status
Recruiting
Location
Uniklinik RWTH Aachen, Department of Internal Medicine
Start Date
2023-01-10
Trial ID
NCT06019130
Nivolumab (BMS-936558) is a fully human, IgG4 (kappa) isotype mAb that bind...
Status
Active Not Recruiting
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Start Date
2019-08-08
Trial ID
NCT04015778
This phase Ib trial studies the side effects of nivolumab and to see how we...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-07-16
Trial ID
NCT03816345
The primary objective of this study is to assess the major pathological res...
Status
Recruiting
Location
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto
Start Date
2023-10-10
Trial ID
NCT06667154
Treatments Being Tested